Celldex Therapeutics Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
Latest Filings
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Celldex Therapeutics Inc
TickerCLDX
CIK #0000744218
CUSIP15117B103
SectorLife Sciences - In Vitro & In Vivo Diagnostic Substances
Address119 Fourth Ave, Needham, MA 02494
Source [EDGAR]
CIK Filing 2011 - 2024
[0000744218] 10-K
[0000744218] 10-Q
[0000744218] 3
[0000744218] 4
[0000744218] 8-K
[0000744218] D
[0000744218] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Wellington Management Group LLP Celldex Therapeutics Inc [2023-02-06] 0.87
Viking Global Investors LP Celldex Therapeutics Inc [2022-06-10] 5.1
State Street Corp Celldex Therapeutics Inc [2022-02-10] 5.07
Vanguard Group Inc Celldex Therapeutics Inc [2022-02-09] 5.17
BlackRock Inc Celldex Therapeutics Inc [2022-02-04] 6.6
FMR LLC Celldex Therapeutics Inc [2021-10-12] 0.0
Cowen Financial Products LLC Celldex Therapeutics Inc [2021-02-25] 5.0939
Redmile Group LLC Celldex Therapeutics Inc [2021-02-16] 6.9
Logos Global Management LP Celldex Therapeutics Inc [2020-10-22] 4.3
Adage Capital Partners GP LLC Celldex Therapeutics Inc [2020-07-24] 5.01
Biotechnology Value Fund L P Celldex Therapeutics Inc [2020-06-26] 3.8
RTW Investments LP Celldex Therapeutics Inc [2020-06-19] 0.95
Ikarian Capital LLC Celldex Therapeutics Inc [2020-06-18] 7.1
Renaissance Technologies LLC Celldex Therapeutics Inc [2020-02-12] 6.91
Columbia Wanger Asset Management LLC Celldex Therapeutics Inc [2017-02-10] 5.1
KLP Enterprises LLC Celldex Therapeutics Inc [2016-12-09] 5.7
State Street Corp Celldex Therapeutics Inc [2016-04-08] 8.67
First Trust Portfolios LP Celldex Therapeutics Inc [2016-01-27] 7.53
Vanguard Group Inc Celldex Therapeutics Inc [2014-02-12] 5.59
Franklin Resources Inc Celldex Therapeutics Inc [2014-02-11] 0.0
FMR LLC Celldex Therapeutics Inc [2013-09-10] 0.0
SAC Capital Advisors LP Celldex Therapeutics Inc [2013-04-22] 4.9
SAC Capital Advisors LP Celldex Therapeutics Inc [2013-04-05] 4.9
Prudential Financial Inc Celldex Therapeutics Inc [2013-02-13] 5.9
Jennison Associates LLC Celldex Therapeutics Inc [2013-02-11] 5.7
BlackRock Inc Celldex Therapeutics Inc [2013-01-30] 8.65
Ridgeback Capital Investments LP Celldex Therapeutics Inc [2012-12-28] 6.1
Form 3/4/5 Filer 2011 - 2024
Jain Rita
Celldex Therapeutics, Inc.
Keler Tibor
Cavanaugh Sarah
Young Diane C.
Wright Richard M.
Marucci Anthony S
Martin Samuel Bates
Jimenez Freddy A.
Neil Garry Arthur
Cohen Cheryl
Heath-Chiozzi Margo
Crowley Elizabeth
Pepin Ronald
Penner Harry Jr
Conrad Herbert J
Brownlie Keith L
Marino James J
Shoos Karen L.
McMahon Gerald PhD
Ellberger Larry
Davis Thomas Andrew
LaVallee Theresa
Catlin Avery W
Elston George
van den Broek Richard
Shannon Timothy M
Form 13F Holdings
Firm Period DFND Voting Shares
FMR LLC [2023-03-31] DFND 7,036,511.0 7,081,078.0
Wellington Management Group LLP [2023-03-31] DFND 0.0 4,181,611.0
BlackRock Inc. [2023-03-31] SOLE 3,170,092.0 3,250,638.0
RTW Investments LP [2023-03-31] SOLE 3,084,215.0 3,084,215.0
Vanguard Group Inc [2023-03-31] SOLE 0.0 2,470,808.0
State Street Corp [2023-03-31] DFND 2,201,155.0 2,302,525.0
Polar Capital Holdings Plc [2023-03-31] DFND 2,267,989.0 2,267,989.0
Redmile Group LLC [2023-03-31] SOLE 1,879,739.0 1,879,739.0
Bellevue Group AG [2023-03-31] DFND 1,800,000.0 1,800,000.0
RA Capital Management LP [2023-03-31] SOLE 0.0 1,734,972.0
Jennison Associates LLC [2023-03-31] DFND 1,456,077.0 1,456,077.0
Kynam Capital Management LP [2023-03-31] SOLE 1,409,451.0 1,409,451.0
Eventide Asset Management LLC [2023-03-31] SOLE 1,377,740.0 1,377,740.0
Citadel Advisors LLC [2023-03-31] DFND 1,370,046.0 1,370,046.0
Geode Capital Management LLC [2023-03-31] DFND 925,708.0 925,708.0
Pictet Asset Management Sa [2023-03-31] DFND 1.0 779,628.0
Octagon Capital Advisors LP [2023-03-31] SOLE 759,898.0 759,898.0
Eversept Partners LP [2023-03-31] SOLE 689,676.0 689,676.0
Price T Rowe Associates Inc /MD/ [2023-03-31] SOLE 136,556.0 681,048.0
Candriam SCA [2023-03-31] SOLE 595,509.0 595,509.0
Commodore Capital LP [2023-03-31] SOLE 495,823.0 495,823.0
Morgan Stanley [2023-03-31] DFND 454,325.0 493,045.0
Northern Trust Corp [2023-03-31] DFND 22,203.0 480,133.0
Dimensional Fund Advisors LP [2023-03-31] SOLE 443,366.0 459,673.0
Rock Springs Capital Management LP [2023-03-31] SOLE 421,504.0 421,504.0
Sofinnova Investments Inc [2023-03-31] SOLE 419,397.0 419,397.0
Susquehanna International Group LLP [2023-03-31] DFND 61,406.0 393,806.0
Fred Alger Management LLC [2023-03-31] SOLE 364,273.0 364,273.0
Bank of America Corp /DE/ [2023-03-31] DFND 6,643.0 361,517.0
Goldman Sachs Group Inc [2023-03-31] DFND 360,148.0 360,173.0
Prev | Page 1 | Next
Terms | Privacy | Guide
tony@aum13f.com